|
|
Volumn 33, Issue 2, 2003, Pages 86-88
|
|
Drug treatment costs: Projected impact of using the integrated management of childhood illnesses
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPICILLIN PLUS CLOXACILLIN;
ANALGESIC AGENT;
ANTHELMINTIC AGENT;
ANTIANEMIC AGENT;
ANTIBIOTIC AGENT;
ANTIMALARIAL AGENT;
ASCORBIC ACID;
CHLORAMPHENICOL;
CHLOROQUINE;
COTRIMOXAZOLE;
ERYTHROMYCIN;
EXPECTORANT AGENT;
FANSIDAR;
FOLIC ACID;
IRON;
METRONIDAZOLE;
MULTIVITAMIN;
ORAL REHYDRATION SOLUTION;
PARACETAMOL;
PROCAINE PENICILLIN;
PYRANTEL EMBONATE;
RETINOL;
VITAMIN B COMPLEX;
ALGORITHM;
ARTICLE;
CHILD CARE;
CHILDHOOD DISEASE;
CLINICAL FEATURE;
CLINICAL PRACTICE;
CONTROLLED STUDY;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DISEASE CLASSIFICATION;
DRUG COST;
DRUG EFFICACY;
DRUG UTILIZATION;
EVALUATION;
FEMALE;
HEALTH CARE COST;
HEALTH CARE FACILITY;
HEALTH CARE PERSONNEL;
HUMAN;
INFANT;
INJECTION;
MAJOR CLINICAL STUDY;
MALE;
NIGERIA;
PATIENT COUNSELING;
PATIENT REFERRAL;
POLYPHARMACY;
PRACTICE GUIDELINE;
PRESCHOOL CHILD;
PRESCRIPTION;
PRIMARY HEALTH CARE;
SKILL;
SURVIVAL RATE;
SYRUP;
TABLET;
TECHNIQUE;
CHILD HEALTH SERVICES;
CHILD, PRESCHOOL;
COSTS AND COST ANALYSIS;
DELIVERY OF HEALTH CARE, INTEGRATED;
DRUG COSTS;
DRUG UTILIZATION;
FEMALE;
HUMANS;
INFANT;
MALE;
NATIONAL HEALTH PROGRAMS;
NIGERIA;
PRACTICE GUIDELINES;
GARI;
|
|
EID: 0037383525
PISSN: 00494755
EISSN: 17581133
Source Type: Journal
DOI: 10.1177/004947550303300210 Document Type: Article |
|
Times cited : (10)
|
|
References (4)
|
